🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. Simvastatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperlipidemias

    small molecule active

    1 trial

  2. Single dose of 2L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Health Behavior

    small molecule completed

    1 trial

  3. Siwu Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Hypoperfusion Syndrome

    small molecule active

    1 trial

  4. Solifenacin Succinate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Overactive Bladder

    small molecule active

    1 trial

  5. Spleen Invigorating and Weight Reducing Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Traditional Chinese Medicine Treatment

    small molecule active

    1 trial

  6. Split dose of 4L PEG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Health Behavior

    small molecule active

    1 trial

  7. Stereotactic body radiotherapy (SBRT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    other active

    1 trial

  8. Study Product A (High-dose 2X)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperuricemia

    other active

    1 trial

  9. Subconjunctival dexamethasone and general anesthesia

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule active

    1 trial

  10. Surgery combined with Target-reduction intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial

  11. Surgery-radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    other active

    1 trial

  12. TNK plus standard medical treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    small molecule active

    1 trial

  13. TPO-RA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenic Purpura

    small molecule active

    1 trial

  14. Tacrolimus+Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    small molecule completed

    1 trial

  15. Tadalafil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Arterial Hypertension (PAH)

    small molecule active

    1 trial

  16. Tafolecimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Coronary Syndrome

    small molecule active

    1 trial

  17. Tamsulosin Hydrochloride

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Benign Prostatic Hyperplasia

    small molecule active

    1 trial

  18. Telmisartan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    small molecule completed

    1 trial

  19. Terlipressin treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    small molecule completed

    1 trial

  20. Ticagrelor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Disease

    small molecule active

    1 trial

  21. Tislelizumab combined with Lenvatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Initially Unresectable Hepatocellular Carcinoma

    small molecule active

    1 trial

  22. Topical compound tripterygium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Active Rheumatoid Arthritis

    small molecule completed

    1 trial

  23. Topical diclofenac sodium gel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hand Osteoarthritis

    small molecule active

    1 trial

  24. Traditional Chinese Medicine treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Frail Elderly Patients

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources